KMT2D and Cirrhosis: Among the mutations identified in the cfDNA of subjects with advanced fibrosis/cirrhosis, somatic mutations in TP53, APC, KMT2C, KMT2D, ATM, and ERBB2 were also reported in the liver with chronic liver diseases, including cirrhosis [51,52,53].